Nonsteroidal anti-inflammatory drugs repress β-secretase gene promoter activity by the activation of PPARγ
Magdalena Sastre(Hammersmith Hospital), Michael T. Heneka(University of Bonn), Peter Borghgraef(Allen Institute for Brain Science), Jochen Walter(University of Bonn), Dietmar Rudolf Thal(Allen Institute for Brain Science), Thomas Klockgether(University of Bonn), Lucia Dumitrescu‐Ozimek(Allen Institute for Brain Science), Nenad Bogdanović(Karolinska Institutet), Bernd O. Evert(Allen Institute for Brain Science), Gary E. Landreth(Indiana University School of Medicine), Ilse Dewachter(Hasselt University), Evan D. Rosen(Broad Institute), Fred Van Leuven(KU Leuven), Steffen Roßner(Allen Institute for Brain Science)
Cited by 373
Related Papers
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
|Neurology|2002|3.5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
|Journal of Neuropathology & Experimental Neurology|2011|2.3k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k